Hyperlipoproteinemia: genes and variants

Explore variant evidence for Hyperlipoproteinemia across 5 analyzed proteins (LPL, APOA5, APOE, APOC2, HMGCR). Linked ClinVar records include 44 pathogenic or likely pathogenic variants, 32 variants of uncertain significance and 14 with conflicting classifications.

Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.

Data updated 2026-11-05. Automated aggregation, not a clinical review date.

Download variant evidence (CSV)

Genes linked to Hyperlipoproteinemia

ClinVar pathogenic and likely pathogenic variants linked to Hyperlipoproteinemia

VariantPositionProtein partClinical label
LPL G181R181Pathogenic / likely pathogenic (★★)
LPL G181S181Pathogenic / likely pathogenic (★★)
LPL R270C270Pathogenic / likely pathogenic (★★)
LPL H273R273Pathogenic / likely pathogenic (★★)
LPL D183N183Pathogenic / likely pathogenic (★★)
LPL R270H270Pathogenic / likely pathogenic (★★)
LPL L279R279Pathogenic / likely pathogenic (★★)
LPL G186E186Pathogenic / likely pathogenic (★★)
LPL C243S243Essential for determining substrate specificityPathogenic / likely pathogenic (★★)
LPL H268Y268Pathogenic / likely pathogenic (★★)
LPL L279V279Pathogenic / likely pathogenic (★★)
LPL P234L234Pathogenic / likely pathogenic (★★)
LPL E269K269Pathogenic / likely pathogenic (★★)
LPL W113R113Pathogenic / likely pathogenic (★★)
LPL G237D237Pathogenic / likely pathogenic (★★)
LPL P241S241Pathogenic / likely pathogenic (★★)
LPL V227A227Pathogenic / likely pathogenic (★★)
LPL D277N277Pathogenic / likely pathogenic (★★)
LPL V96L96Pathogenic / likely pathogenic (★★)
LPL A98T98Pathogenic / likely pathogenic (★★)
LPL I252T252Essential for determining substrate specificityPathogenic / likely pathogenic (★★)
LPL S286G286Pathogenic / likely pathogenic (★★)
LPL K331E331Pathogenic / likely pathogenic (★★)
LPL M1I1Pathogenic / likely pathogenic (★★)
LPL C266Y266Essential for determining substrate specificityPathogenic / likely pathogenic (★)
LPL G169E169Pathogenic / likely pathogenic (★)
LPL S278C278Pathogenic / likely pathogenic (★)
LPL A203T203Pathogenic / likely pathogenic (★)
LPL T211K211Pathogenic / likely pathogenic (★)
LPL S220R220Pathogenic / likely pathogenic (★)
LPL C310R310Pathogenic / likely pathogenic (★)
LPL Y289H289Pathogenic / likely pathogenic (★)
LPL L392V392PLATPathogenic / likely pathogenic (★)
LPL R116Q116Pathogenic / likely pathogenic (★)
LPL R333C333Pathogenic / likely pathogenic (★)
LPL D183G183Pathogenic / likely pathogenic
LPL C266W266Essential for determining substrate specificityPathogenic / likely pathogenic
LPL H273P273Pathogenic / likely pathogenic
LPL S271T271Pathogenic / likely pathogenic
LPL S199C199Pathogenic / likely pathogenic
LPL G222E222Pathogenic / likely pathogenic
LPL D231E231Pathogenic / likely pathogenic
LPL C445Y445PLATPathogenic / likely pathogenic
LPL R197H197Pathogenic / likely pathogenic

Uncertain variants prioritized for review in Hyperlipoproteinemia

VariantPositionProtein partClinical labelEvidence
LPL R116P116Conflicting reports (★)+7: 2 other pathogenic changes within 3 positions; R116Q at the same position is pathogenic; seen in 6.6e-06 of gnomAD DNA copies; REVEL 0.813
LPL H268Q268Conflicting reports (★)+7: 7 other pathogenic changes within 3 positions; H268Y at the same position is pathogenic; seen in 6.8e-07 of gnomAD DNA copies; REVEL 0.892
LPL R333H333Conflicting reports (★)+6: 2 other pathogenic changes within 3 positions; R333C at the same position is pathogenic; REVEL 0.795

Which prediction tools work for Hyperlipoproteinemia

Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.

Same protein, different disease

Diseases related to Hyperlipoproteinemia

Frequently asked questions

Which genes have records linked to Hyperlipoproteinemia?

This view contains 5 analyzed proteins: LPL, APOA5, APOE, APOC2, HMGCR. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.

What do the clinical classifications mean?

Linked records include 44 pathogenic or likely pathogenic variants, 32 variants of uncertain significance and 14 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.

Does the evidence score change a VUS classification?

No. 3 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.

Can I download the variant evidence?

Download the CSV for all 131 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.

About this data

Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.

Download every variant as CSV · Browse all diseases · Methods · About the Center